Navigation Links
U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age)
Date:2/29/2008

rom baseline to Week 4. Safety evaluations included incidence of adverse reactions, discontinuation due to adverse reactions, laboratory measures and body weight.

For the primary endpoint, both doses of ABILIFY demonstrated statistically significant improvement in symptoms when compared to placebo (p-value less than 0.0001) as measured by the mean change from baseline to endpoint (Week 4) on the Y-MRS Total Score. The efficacy of ABILIFY for the maintenance treatment of Bipolar I Disorder in the pediatric population has not been evaluated.

Approximately 80% of patients completed the four-week study (ABILIFY 10 mg: 86%; ABILIFY 30 mg: 78%; placebo: 77%). There was a low rate of discontinuation due to adverse reactions at Week 4 (ABILIFY: 7%; placebo: 2%).

During the study, the most commonly observed adverse reactions (greater than or equal to 5% in combined ABILIFY groups and at least twice the rate of placebo) associated with ABILIFY were: somnolence (ABILIFY: 23%; placebo: 3%), extrapyramidal disorder (ABILIFY: 20%; placebo: 3%), fatigue (ABILIFY: 11%; placebo: 4%), nausea (ABILIFY: 11%; placebo: 4%), akathisia (ABILIFY: 10%; placebo: 2%), blurred vision (ABILIFY: 8%; placebo: 0%), salivary hypersecretion (ABILIFY: 6%; placebo: 0%) and dizziness (ABILIFY: 5%; placebo: 1%). Four common adverse reactions had a possible dose-response relationship at Week 4: extrapyramidal disorder (ABILIFY 10 mg: 12.2%; ABILIFY 30 mg: 27.3%; placebo: 3.1%), somnolence (ABILIFY 10 mg: 19.4%; ABILIFY 30 mg: 26.3%; placebo: 3.1%), akathisia (ABILIFY 10 mg: 8.2%; ABILIFY 30 mg: 11.1%; placebo: 2.1%) and salivary hypersecretion (ABILIFY 10 mg: 3.1%; ABILIFY 30 mg: 8.1%; placebo: 0%). Children and adolescents might be more sensitive than adults in developing antipsychotic-related adverse events.(1)

In the study, weight gain greater than or equal to 7% change from baseline was seen in 3.2%, 9.4% and 3.3% for the ABILIFY 10 mg, ABILIFY 30 mg and placebo groups, res
'/>"/>

SOURCE Otsuka Pharmaceutical Co., Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Biological Psychiatry Publishes Study Showing VYVANSE Demonstrated Significant Efficacy for Treatment of ADHD for up to 12 Hours After Administration
2. Supplemental New Drug Application for PREZISTA(TM) Submitted to U.S. Food and Drug Administration
3. Northwestern Offers Clinical Research and Regulatory Administration Graduate Certificate Program
4. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
5. Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV
6. FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder
7. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
8. FDA Approves MiddleBrooks Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
9. FDA Approves XYZAL(R) (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria
10. UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies
11. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... 4, 2015  Neurocrine Biosciences, Inc. (NASDAQ: NBIX ... has joined the company as Vice President, Medical Affairs. ... Dr. Bill Aurora to the Neurocrine team ... Gorman , President and Chief Executive Officer of Neurocrine ... and outreach coupled with his extensive network and influence ...
(Date:5/4/2015)... Microbrush International, a leading developer, producer and ... procedures, today announced the acquisition of DentiSmart LLC. ... matrix system used in dental restorative procedures. ... to add DentiSmart to our growing portfolio of ... and General Manager of Microbrush. "DentiSmart,s products are ...
(Date:5/4/2015)... , May 4, 2015  The board of directors of ... a dividend for the second quarter of 2015 of $0.50 ... dividend is payable June 10, 2015, to shareholders of record ... About Eli Lilly and Company Lilly is a global healthcare ... for people around the world. We were founded more than ...
Breaking Medicine Technology:Neurocrine Biosciences, Inc. Announces Appointment of Dr. Bill Aurora as Vice President, Medical Affairs 2Neurocrine Biosciences, Inc. Announces Appointment of Dr. Bill Aurora as Vice President, Medical Affairs 3Microbrush International Announces Acquisition of DentiSmart 2
... Lexicon Pharmaceuticals, Inc. (Nasdaq: ... treatments for human disease, announced today that Arthur ... executive officer, will present at the Stifel Nicolaus Healthcare ... 2:40 p.m. Eastern Time.  Dr. Sands will provide an ...
... Aug. 30, 2011 Reportlinker.com announces that a ... its catalogue: Specialty Pharmaceutical ... http://www.reportlinker.com/p0512130/Specialty-Pharmaceutical-Industry---2011-Yearbook.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology Summary ... Industry - 2011 Yearbook" essentially provides insights ...
Cached Medicine Technology:Lexicon Pharmaceuticals to Present at Stifel Nicolaus Healthcare Conference 2Specialty Pharmaceutical Industry - 2011 Yearbook 2Specialty Pharmaceutical Industry - 2011 Yearbook 3Specialty Pharmaceutical Industry - 2011 Yearbook 4Specialty Pharmaceutical Industry - 2011 Yearbook 5Specialty Pharmaceutical Industry - 2011 Yearbook 6Specialty Pharmaceutical Industry - 2011 Yearbook 7Specialty Pharmaceutical Industry - 2011 Yearbook 8Specialty Pharmaceutical Industry - 2011 Yearbook 9Specialty Pharmaceutical Industry - 2011 Yearbook 10Specialty Pharmaceutical Industry - 2011 Yearbook 11Specialty Pharmaceutical Industry - 2011 Yearbook 12Specialty Pharmaceutical Industry - 2011 Yearbook 13Specialty Pharmaceutical Industry - 2011 Yearbook 14Specialty Pharmaceutical Industry - 2011 Yearbook 15Specialty Pharmaceutical Industry - 2011 Yearbook 16
(Date:5/5/2015)... (PRWEB) May 05, 2015 With the advent ... and enjoying the feel of warm breezes on bare skin. ... strategies on how to look their best in shorts, tank ... and more people are turning to laser treatments for permanent ... of Simply Posh Aesthetic Spa . “They're all veterans ...
(Date:5/5/2015)... 05, 2015 “We currently have larger size casual ... Phillips, owner of SunGrubbies.com. “We felt it was time to ... a fashionable sun hat in an extra large size that they ... Fashionable derby sun hats such as the Rebecca, Chloe, ... now available in an extra large size , fitting heads ...
(Date:5/5/2015)... There have been numerous attempts to ... on personal lines (home, auto, etc). Now, for the ... (NDOI.com) has created an online vehicle for more than ... present their expertise in all realms of insurance directly ... and two-fold. , First, the online, searchable database improves ...
(Date:5/5/2015)... NY (PRWEB) May 05, 2015 No one ... Centers for Disease Control and Prevention cite multiple ... our everyday life: “Poor indoor air quality (pollution) can bother ... chronic heart and lung problems and cancer.” , Toxic chemicals ... them in contaminated food or water, or in some cases, ...
(Date:5/4/2015)... 2015 Visiopharm, the leader in image ... of a private round of financing with NorthCap ... investment will assist Visiopharm to further accelerate business growth ... image analysis driven diagnostic digital pathology solutions. , "It ... ONCOtopix™ Dx solution has energized the pathologists, and ...
Breaking Medicine News(10 mins):Health News:Laser Hair Removal: Tips for Summertime Grooming 2Health News:Laser Hair Removal: Tips for Summertime Grooming 3Health News:SunGrubbies.com, a Leading Online Retailer of Sun Protection Products, Launches Their New Extra Large Size Fashion Sun Hats Collection 2Health News:NDOI Launch Brings Commercial Insurance Online for the First Time 2Health News:NDOI Launch Brings Commercial Insurance Online for the First Time 3Health News:revitaRUGS is Offering Area Rug Cleaning Discounts in Support of Asthma and Allergy Awareness Month This May 2Health News:revitaRUGS is Offering Area Rug Cleaning Discounts in Support of Asthma and Allergy Awareness Month This May 3Health News:Visiopharm Closes Investment Round to Grow Diagnostic Digital Pathology Business 2Health News:Visiopharm Closes Investment Round to Grow Diagnostic Digital Pathology Business 3
... have to wait for access to public health care.// ... the mandatory three-month waiting period for OHIP coverage for the ... George Smitherman the evacuees have undergone a lot of stress ... they need when they need it the most." ...
... conference of Health Ministers of Southern States will be ... taken for controlling chikungunya,Karnataka Health Minister R Ashok said ... of submitting a memorandum to the Centre seeking financial ... ,The Karnataka government had decided to provide fogging ...
... study carried out by a group of researchers, at ... link between periodontal bacteria and acute// coronary syndrome (ACS). ... of alveolar bone loss was significantly greater among those ... of the study participants in the ACS group showed ...
... surgery permanently damaging your eye? AIIMS has introduced a ... near or far sightedness through the insertion of small ... typical vision correction procedure using intrastromal corneal rings (INTACS) ... of the eye and inserting two crescent shaped rings ...
... of people living with HIV/AIDS in the country do ... United Nations study has said. // ,"Seventy-four ... HIV-positive status at their workplace. Of the remaining 26 ... cent have reported facing discrimination at the hands of ...
... the classroom to keep school-age children and teens from lighting ... is little strong evidence that school-based programs are effective in ... said Dr. Roger Thomas, lead reviewer and a professor in ... Alberta, Canada. ,The review appears in the July ...
Cached Medicine News:Health News:Students Light Up Despite School Anti-Smoking Programs 2Health News:Students Light Up Despite School Anti-Smoking Programs 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: